Compounds > sibutramine
Page last updated: 2024-08-16

sibutramine and prazosin

sibutramine has been researched along with prazosin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bearham, MC; Heal, DJ; Hutchins, LJ; Jackson, HC; Mazurkiewicz, SE; Needham, AM1
Nakagawa, T; Nakanishi, H; Ohyama, T; Ukai, K1
Adan, RA; Janhunen, SK; la Fleur, SE; van der Zwaal, EM1

Reviews

1 review(s) available for sibutramine and prazosin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for sibutramine and prazosin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi

2010
Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat.
    British journal of pharmacology, 1997, Volume: 121, Issue:8

    Topics: Adrenergic Uptake Inhibitors; Animals; Cyclobutanes; Eating; Idazoxan; Male; Metoprolol; Prazosin; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors

1997
Sibutramine induces potential-dependent exocytotic release but not carrier-mediated release of dopamine and 5-hydroxytryptamine.
    European journal of pharmacology, 2004, Jan-26, Volume: 484, Issue:2-3

    Topics: Animals; Corpus Striatum; Cyclobutanes; Dopamine; Dothiepin; Exocytosis; Injections, Intraventricular; Male; Microdialysis; Perfusion; Prazosin; Rats; Rats, Wistar; Serotonin; Tetrodotoxin

2004
Inverse agonism at α2A adrenoceptors augments the hypophagic effect of sibutramine in rats.
    Obesity (Silver Spring, Md.), 2011, Volume: 19, Issue:10

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Appetite Depressants; Cyclobutanes; Energy Intake; Feeding Behavior; Hyperphagia; Locomotion; Male; Metergoline; Norepinephrine; Obesity; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Satiety Response; Serotonin Receptor Agonists

2011